专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08030029B2 Flu vaccines and methods of use thereof 有权
公开(公告)号：US08030029B2
公开(公告)日：2011-10-04
申请号：US12011032
申请日：2008-01-23
申请人： David D. Ho , Yaoxing Huang , Ming Wei Chen , Rachel TJ Cheng , Chi-Huey Wong , Alice Yu
发明人： David D. Ho , Yaoxing Huang , Ming Wei Chen , Rachel TJ Cheng , Chi-Huey Wong , Alice Yu
IPC分类号： C12N15/44 , A61K48/00
CPC分类号： C07K14/005 , A61K39/12 , A61K39/145 , A61K2039/53 , A61K2039/58 , C12N2760/16122 , C12N2760/16134
摘要： This disclosure is directed, inter alia, to polynucleotides, polypeptides, vectors, cells and compositions comprising the same, and their use in affecting viral pathogenesis, in particular for influenza viral infection.

2. 发明申请

US20100041740A1 FLU VACCINES AND METHODS OF USE THEREOF 有权
标题翻译：流感疫苗及其使用方法
公开(公告)号：US20100041740A1
公开(公告)日：2010-02-18
申请号：US12417556
申请日：2009-04-02
申请人： Chi-Huey Wong , David D. Ho , Yaoxing Huang , Ting-Jen R. Cheng , Ming Wei Chen , Alice Yu
发明人： Chi-Huey Wong , David D. Ho , Yaoxing Huang , Ting-Jen R. Cheng , Ming Wei Chen , Alice Yu
IPC分类号： A61K31/7088 , C07H21/04 , C07K16/00 , C12N15/63
CPC分类号： A61K39/145 , A61K39/12 , A61K2039/505 , A61K2039/53 , A61K2039/58 , A61K2039/70 , C07K14/005 , C07K16/1018 , C07K2317/76 , C12N2760/16122 , C12N2760/16134
摘要： This disclosure is directed, inter alia, to polynucleotides, polypeptides, vectors, cells and compositions comprising the same, and their use in affecting viral pathogenesis, in particular for influenza viral infection.
摘要翻译：本公开特别涉及多核苷酸，多肽，载体，细胞和包含其的组合物，以及它们在影响病毒发病机理中的用途，特别是针对流感病毒感染的用途。

3. 发明授权

US07981428B2 Flu vaccines and methods of use thereof 有权
标题翻译：流感疫苗及其使用方法
公开(公告)号：US07981428B2
公开(公告)日：2011-07-19
申请号：US12417556
申请日：2009-04-02
申请人： Chi-Huey Wong , David D. Ho , Yaoxing Huang , Ting-Jen R. Cheng , Ming Wei Chen , Alice Yu
发明人： Chi-Huey Wong , David D. Ho , Yaoxing Huang , Ting-Jen R. Cheng , Ming Wei Chen , Alice Yu
IPC分类号： A61K39/145 , A61K48/00 , C12N15/44 , C12N7/00
CPC分类号： A61K39/145 , A61K39/12 , A61K2039/505 , A61K2039/53 , A61K2039/58 , A61K2039/70 , C07K14/005 , C07K16/1018 , C07K2317/76 , C12N2760/16122 , C12N2760/16134
摘要： This disclosure is directed, inter alia, to polynucleotides, polypeptides, vectors, cells and compositions comprising the same, and their use in affecting viral pathogenesis, in particular for influenza viral infection.
摘要翻译：本公开特别涉及多核苷酸，多肽，载体，细胞和包含其的组合物，以及它们在影响病毒发病机理中的用途，特别是针对流感病毒感染的用途。

4. 发明申请

US20090060949A1 Flu vaccines and methods of use thereof 有权
标题翻译：流感疫苗及其使用方法
公开(公告)号：US20090060949A1
公开(公告)日：2009-03-05
申请号：US12011032
申请日：2008-01-23
申请人： David D. Ho , Yaoxing Huang , Ming Wei Chen , Rachel T.J. Cheng , Chi-Huey Wong , Alice Yu
发明人： David D. Ho , Yaoxing Huang , Ming Wei Chen , Rachel T.J. Cheng , Chi-Huey Wong , Alice Yu
IPC分类号： A61K39/145 , C07H21/04 , C07K14/00 , C07K16/08 , A61P37/04 , C12N15/09 , C12N15/64 , A61K31/711
CPC分类号： C07K14/005 , A61K39/12 , A61K39/145 , A61K2039/53 , A61K2039/58 , C12N2760/16122 , C12N2760/16134
摘要： This disclosure is directed, inter alia, to polynucleotides, polypeptides, vectors, cells and compositions comprising the same, and their use in affecting viral pathogenesis, in particular for influenza viral infection.
摘要翻译：本公开特别涉及多核苷酸，多肽，载体，细胞和包含其的组合物，以及它们在影响病毒发病机理中的用途，特别是针对流感病毒感染的用途。

5. 发明申请

US20080260774A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies 审中-公开
标题翻译： α-半乳糖基神经酰胺类似物及其作为免疫治疗的用途
公开(公告)号：US20080260774A1
公开(公告)日：2008-10-23
申请号：US12082751
申请日：2008-04-14
申请人： Chi-Huey Wong , Alice Yu , Ya-Jen Chang
发明人： Chi-Huey Wong , Alice Yu , Ya-Jen Chang
IPC分类号： A61K39/00 , A61K31/35 , C07D315/00 , A61P37/00
CPC分类号： C07H15/26 , A61K8/68 , A61K2800/91 , A61Q17/005 , C07H15/06 , C07H15/18
摘要： The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect, a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: wherein, n is 0 to 25; X is selected from O and S; R1 is selected from H, CH3, and phenyl, where phenyl is optionally substituted with H, OH, OCH3, F, CF3, phenyl, phenyl-F, C1-C6 alkyl, or C2-C6 branched alkyl; R2 is selected from OH and H; R3 is selected from C1-C15 alkyl, and phenyl, where phenyl is optionally substituted with H, OH, OCH3, F, CF3, phenyl, C1-C6 alkyl, or C2-C6 branched alkyl; R4 is selected from OH, OSO3H, OSO3Na, and OSO3K; and R5 is selected from CH2OH and CO2H; or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response.
摘要翻译：本公开涉及合成的α-半乳糖神经酰胺（α-GalCer）类似物，以及它们作为免疫治疗的用途。一方面，在受试者中激活细胞因子应答的方法包括向受试者施用有效量的化合物，其中所述受试者具有包括细胞群的适应性免疫系统，所述群体包括至少一种淋巴细胞，并且在至少一种抗原呈递细胞，并且其中所述化合物由式1的结构表示：其中n为0至25; X选自O和S; R 1选自H，CH 3和苯基，其中苯基任选被H，OH，OCH 3，F，CF 苯基，苯基-F，C 1 -C 6烷基或C 2 -C 6亚烷基 >支链烷基; R 2选自OH和H; R 3选自C 1 -C 15烷基和苯基，其中苯基任选被H，OH，OCH 3取代， 3，F，CF 3，苯基，C 1 -C 6烷基或C 2 H 2 -C 6 -C 6支链烷基; R 4选自OH，OSO 3 H，OSO 3 Na和OSO 3 K; 和R 5选自CH 2 OH和CO 2 H; 或其药学上可接受的盐; 在化合物和抗原呈递细胞之间形成复合物，其中复合物的形成导致淋巴细胞上受体的活化; 并激活淋巴细胞以产生细胞因子反应。

6. 发明授权

US07928077B2 Alpha-galactosyl ceramide analogs and their use as immunotherapies 有权
标题翻译： α-半乳糖基神经酰胺类似物及其作为免疫治疗的用途
公开(公告)号：US07928077B2
公开(公告)日：2011-04-19
申请号：US12218082
申请日：2008-07-11
申请人： Chi-Huey Wong , Alice Yu , Ya-Jen Chang , Kun-Hsien Lin , Jung-Tung Hung
发明人： Chi-Huey Wong , Alice Yu , Ya-Jen Chang , Kun-Hsien Lin , Jung-Tung Hung
IPC分类号： A61K31/7032 , C07H15/18
CPC分类号： C07H15/18 , A61K31/7034 , A61K39/0011 , A61K2039/57 , Y02A50/388 , Y02A50/39 , Y02A50/48
摘要： The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response.
摘要翻译：本公开涉及合成的α-半乳糖神经酰胺（α-GalCer）类似物，以及它们作为免疫治疗的用途。在一个方面在受试者中激活细胞因子应答的方法包括向受试者施用有效量的化合物，其中受试者具有包括细胞群的适应性免疫系统，所述群体包括至少一种淋巴细胞和至少一种抗原 - 呈递细胞，并且其中所述化合物由式1的结构表示：或其药学上可接受的盐; 在化合物和抗原呈递细胞之间形成复合物，其中复合物的形成导致淋巴细胞上受体的活化; 并激活淋巴细胞以产生细胞因子反应。

7. 发明申请

US20100136042A1 GLOBO H AND RELATED ANTI-CANCER VACCINES WITH NOVEL GLYCOLIPID ADJUVANTS 有权
标题翻译： GLOBO H和相关的抗癌药物与新型甘露醇辅剂
公开(公告)号：US20100136042A1
公开(公告)日：2010-06-03
申请号：US12537129
申请日：2009-08-06
申请人： Chi-Huey Wong , Chung-Yi Wu , Alice Yu , John Yu
发明人： Chi-Huey Wong , Chung-Yi Wu , Alice Yu , John Yu
IPC分类号： A61K39/385 , A61P35/04
CPC分类号： A61K39/0011 , A61K2039/55511 , A61K2039/6037 , A61K2039/6081 , A61K2039/627 , C12N15/1137 , C12N2310/14
摘要： Immunogenic compositions, cancer vaccines and methods for treating cancer are provided. Compositions comprising: (a) a glycan such as Globo H or an immunogenic fragment thereof, wherein the glycan is conjugated with a carrier protein by a linker such as para-nitrophenyl; and (b) an adjuvant comprising glycolipid capable of binding CD1d on a dendritic cell, such as an α-galactosyl-ceramide derivative, wherein the immunogenic composition induces an immune response that induces a higher relative level of IgG isotype antibodies as compared to IgM isotype antibodies, are provided. Immunogenic compositions comprising the carrier protein diphtheria toxin cross-reacting material 197 (DT-CRM197) and the adjuvant C34 are provided. Antibodies generated by immunogenic compositions disclosed herein further neutralize at least one of the antigens Globo H, stage-specific embryonic antigen-3 (SSEA-3) and stage-specific embryonic antigen-4 (SSEA-4). Therapeutics against breast cancer stem cells comprising immunogenic compositions comprising Globo H, SSEA-3 or SSEA-4 conjugated with DT-CRM197.
摘要翻译：提供免疫原性组合物，癌症疫苗和治疗癌症的方法。组合物，其包含：（a）聚糖如Globo H或其免疫原性片段，其中所述聚糖通过诸如对硝基苯基之类的接头与载体蛋白缀合; 和（b）包含能够结合树突状细胞上的CD1d的糖脂如α-半乳糖基 - 神经酰胺衍生物的佐剂，其中所述免疫原性组合物诱导与IgM同种型相比诱导更高相对水平的IgG同种型抗体的免疫应答抗体。提供了包含载体蛋白质白喉毒素交叉反应材料197（DT-CRM197）和佐剂C34的免疫原性组合物。由本文公开的免疫原性组合物产生的抗体进一步中和至少一种抗原Globo H，阶段特异性胚胎抗原-3（SSEA-3）和阶段特异性胚胎抗原-4（SSEA-4）。包括含有与DT-CRM197缀合的Globo H，SSEA-3或SSEA-4的免疫原性组合物的乳腺癌干细胞的治疗剂。

8. 发明申请

US20100008954A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies 有权
标题翻译： α-半乳糖基神经酰胺类似物及其作为免疫治疗的用途
公开(公告)号：US20100008954A1
公开(公告)日：2010-01-14
申请号：US12218082
申请日：2008-07-11
申请人： Chi-Huey Wong , Alice Yu , Ya-Jen Chang , Kun-Hsien Lin , Jung-Tung Hung
发明人： Chi-Huey Wong , Alice Yu , Ya-Jen Chang , Kun-Hsien Lin , Jung-Tung Hung
IPC分类号： A61K39/02 , A61K31/7034 , C07H15/18 , A61K39/00
CPC分类号： C07H15/18 , A61K31/7034 , A61K39/0011 , A61K2039/57 , Y02A50/388 , Y02A50/39 , Y02A50/48
摘要： The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response.
摘要翻译：本公开涉及合成的α-半乳糖神经酰胺（α-GalCer）类似物，以及它们作为免疫治疗的用途。在一个方面在受试者中激活细胞因子应答的方法包括向受试者施用有效量的化合物，其中受试者具有包括细胞群的适应性免疫系统，所述群体包括至少一种淋巴细胞和至少一种抗原 - 呈递细胞，并且其中所述化合物由式1的结构表示：或其药学上可接受的盐; 在化合物和抗原呈递细胞之间形成复合物，其中复合物的形成导致淋巴细胞上受体的活化; 并激活淋巴细胞以产生细胞因子反应。

9. 发明申请

US20080214442A1 Anti-Viral Effect of an Extract of Ganoderma Lucidum 审中-公开
标题翻译：灵芝提取物的抗病毒作用
公开(公告)号：US20080214442A1
公开(公告)日：2008-09-04
申请号：US11859729
申请日：2007-09-21
申请人： Alice Yu , Chi-Huey Wong , Jia Tsrong Jan , Y.-S. Edmond Cheng
发明人： Alice Yu , Chi-Huey Wong , Jia Tsrong Jan , Y.-S. Edmond Cheng
IPC分类号： A61K38/16 , C07K14/00 , A61P31/12
CPC分类号： C07K2/00 , A61K36/074 , A61K38/00
摘要： Compositions and methods for the treatment viral infections in organisms, particularly flu virus. The methods and compositions of the disclosure involve the administration to mammals and immune cells of a fucose-containing glycoprotein fraction from Reishi. An extract of G. lucidum induces immune responses that are shown to induce increase survivability in mice injected with lethal does of influenza virus. The effect is increased when the G. lucidum extract is dosed prior to injection of the lethal dose of influenza virus.
摘要翻译：用于治疗生物体中的病毒感染的组合物和方法，特别是流感病毒。本公开的方法和组合物涉及向来自Reishi的含岩藻糖的糖蛋白部分的哺乳动物和免疫细胞施用。灵芝的提取物诱导免疫应答，显示其在注射致死性流感病毒的小鼠中诱导增加的存活能力。当在注射致死剂量的流感病毒之前配制灵芝提取物时，效果增加。

10. 发明授权

US08906380B2 Fungal immunostimulatory compositions 有权
标题翻译：真菌免疫刺激成分
公开(公告)号：US08906380B2
公开(公告)日：2014-12-09
申请号：US11549215
申请日：2006-10-13
申请人： Alice Yu , John Yu , Kuo-I Lin , Wen-Bin Yang , Chi-Huey Wong
发明人： Alice Yu , John Yu , Kuo-I Lin , Wen-Bin Yang , Chi-Huey Wong
IPC分类号： A61K39/00 , A61K39/395 , A61K45/00 , A61K47/00 , A61K39/38 , A61K51/00 , C12N5/00 , C12N5/02 , A01N37/18 , A61K38/00 , A61P31/10 , A61K38/14 , A61K36/074 , A61K39/39 , C12N5/0784
CPC分类号： A61K36/074 , A61K39/39 , A61K2039/57 , C12N5/0639 , C12N2500/74
摘要： Methods are disclosed which are useful in increasing maturation of dendritic cells from CD14+ mononuclear cells, by contact with a composition comprising a fucose-containing glycoprotein fraction from Ganoderma lucidum. The extract can also be used for increasing production of a cytokine or a chemokine in a dendritic cell or CD19+ B cell. In addition, a fucose-containing glycoprotein fraction from Ganoderma lucidum can be administered to a subject identified as needing increased immunoglobulin, cytokine, or chemokine production.
摘要翻译：通过与含有来自灵芝的含岩藻糖的糖蛋白部分的组合物的接触，公开了可用于增加来自CD14 +单核细胞的树突状细胞成熟的方法。提取物也可用于增加树突状细胞或CD19 + B细胞中细胞因子或趋化因子的产生。此外，来自灵芝的含岩藻糖的糖蛋白部分可以施用于被鉴定为需要增加的免疫球蛋白，细胞因子或趋化因子产生的受试者。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式